Tables
- TABLE 1
Frequencies of sex and age of 550 consecutive mediastinal masses encountered in a 5-year period (2017–2021) at the National Hospital for Respiratory Diseases (Welisara, Sri Lanka)
Subjects Sex Age (years) Male Female Range Mean±sd Thymic lesions 171 100 71 12–83 49±17 Cyst 10 7 3 12–68 38±18 Hyperplasia 14 6 8 12–59 28±15 Thymolipoma 1 1 0 34 34 Thymoma 114 57 57 15–82 53±14 Thymic carcinoma (type C) 19 17 2 17–83 52±19 Carcinoid tumour 13 12 1 19–71 46±14 Lymphoma/leukaemia 100 45 55 11–75 33±13 Non-Hodgkin lymphoma 56 33 23 11–75 35±15 Hodgkin lymphoma 40 12 28 13–59 29±10 Unclassified 4 0 4 30–38 35±4 Infectious/inflammatory diseases 75 35 40 17–78 46±15 Tuberculosis 17 4 13 17–59 33±13 Sarcoidosis 35 17 18 17–74 50±12 Granulomatous inflammation unclassified 19 12 7 17–78 50±15 Rosai–Dorfman disease 2 0 2 17–33 25±11 Sinus histiocytosis 2 2 0 63–63 63±0 Germ-cell tumours 67 50 17 3–59 28±11 Seminoma 11 11 0 18–43 25±9 Teratoma 37 20 17 3–59 29±12 Malignant nonseminimatous tumours 19 19 0 5–53 27±12 Metastasis 58 38 20 20–75 56±11 Benign connective tissue tumours 34 18 16 1–72 47±20 Castleman disease 2 2 0 34–57 45±16 Lipoma 1 0 1 69 69 Angioma 3 2 1 25–71 52±24 Schwannoma 21 13 8 23–72 51±15 Neurofibroma 1 0 1 56 56 Ganglioneuroma 6 1 5 1–64 26±25 Developmental cysts 13 6 7 19–66 49±16 Bronchogenic 7 4 3 19–58 40±15 Pleuro-pericardial 2 1 1 42–64 53±16 Unclassified 4 1 3 59–66 63±3 Sarcoma 28 11 17 18–73 42±16 Other unclassified tumours 4 1 3 5–44 24±16 Data are presented as n, unless otherwise stated.